Literature DB >> 25439064

The stomach-brain axis.

Gerald Holtmann1, Nicholas J Talley2.   

Abstract

The stomach has distinct functions in relation to the ingestion and handling of solids and liquids. These functions include storage of the food before it is gradually emptied into the duodenum, mechanical crushing of larger food particles to increase the surface area, secretion of an acidic enzyme rich gastric juice and mixing the ingested food with the gastric juice. In addition, the stomach 'senses' the composition of the gastric content and this information is passed via the vagal nerve to the lateral hypothalamus and the limbic system, most likely as palatability signals that influence eating behaviour. Other sensory qualities related to the stimulation of gastric tension receptors are satiety and fullness. Receptors that respond to macronutrient content or gastric wall tension influence appetite and meal related hormone responses. The ingestion of food - in contrast to an infusion of nutrients into the stomach - has distinct effects on the activation of specific brain regions. Brain areas such as thalamus, amygdala, putamen and praecuneus are activated by the ingestion of food. Gastric nutrient infusion evokes greater activation in the hippocampus and anterior cingulate. The brain integrates these interrelated neural and hormonal signals arising from the stomach as well as visual, olfactory and anticipatory stimuli that ultimately influence eating and other behavioural patterns. Furthermore, there is now good evidence from experimental studies that gastric afferents influence mood, and animal studies point towards the possibility that gastric dysfunction may be a risk factor for mood disorders such as anxiety and depression. The stomach is also not only colonised by Helicobacter pylori but a large array of bacteria. While there is sufficient evidence to suggest that H. pylori may alter caloric intake and mood, the role of other gastric microbiome for the brain function is unknown. To address this appropriate targeted gastric microbiome studies would be required instead of widely utilised opportunistic stool microbiome studies. In summary, it is now well established that there are important links between the brain and the stomach that have significant effects on gastric function. However, the stomach also influences the brain. Disturbances in the crosstalk between the stomach and the brain may manifest as functional GI disorders while disturbances in the stomach-brain communication may also result in an altered regulation of satiety and as a consequence may affect eating behaviour and mood. These observations may enable the identification of novel therapies targeted at the gastroduodenum that positively alter brain function and treat or prevent conditions such as obesity or functional gastrointestinal disorders.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Brain-gut interactions; Functional gastrointestinal disorders; Inflammation; Microbiome; Stomach; Stress

Mesh:

Year:  2014        PMID: 25439064     DOI: 10.1016/j.bpg.2014.10.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  12 in total

1.  Patient-specific stomach biomechanics before and after laparoscopic sleeve gastrectomy.

Authors:  Ilaria Toniolo; Alice Berardo; Mirto Foletto; Claudio Fiorillo; Giuseppe Quero; Silvana Perretta; Emanuele Luigi Carniel
Journal:  Surg Endosc       Date:  2022-04-22       Impact factor: 3.453

2.  Gastric neurons in the nucleus tractus solitarius are selective to the orientation of gastric electrical stimulation.

Authors:  Jiayue Cao; Xiaokai Wang; Terry L Powley; Zhongming Liu
Journal:  J Neural Eng       Date:  2021-10-26       Impact factor: 5.043

Review 3.  Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy.

Authors:  Velimir Altabas; Vanja Zjačić-Rotkvić
Journal:  Immunotargets Ther       Date:  2015-07-09

4.  Comparative metabolomics study on therapeutic mechanism of electro-acupuncture and moxibustion on rats with chronic atrophic gastritis (CAG).

Authors:  Cai-Chun Liu; Jiao-Long Chen; Xiao-Rong Chang; Qi-da He; Jia-Cheng Shen; Lin-Yu Lian; Ya-Dong Wang; Yuan Zhang; Fu-Qiang Ma; Hui-Ying Huang; Zong-Bao Yang
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

5.  Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders : A noninterventional study with Iberogast®.

Authors:  Richard Raedsch; Bettina Vinson; Bertram Ottillinger; Gerald Holtmann
Journal:  Wien Med Wochenschr       Date:  2017-07-25

Review 6.  The Realization of the Brain-Gut Interactions with Corticotropin-Releasing Factor and Glucocorticoids.

Authors:  Ludmila Filaretova; Tatiana Bagaeva
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

7.  Intestinal dysmotility in a zebrafish (Danio rerio) shank3a;shank3b mutant model of autism.

Authors:  David M James; Robert A Kozol; Yuji Kajiwara; Adam L Wahl; Emily C Storrs; Joseph D Buxbaum; Mason Klein; Baharak Moshiree; Julia E Dallman
Journal:  Mol Autism       Date:  2019-01-31       Impact factor: 7.509

Review 8.  The Gut-Brain-Microbiome Axis and Its Link to Autism: Emerging Insights and the Potential of Zebrafish Models.

Authors:  David M James; Elizabeth A Davidson; Julio Yanes; Baharak Moshiree; Julia E Dallman
Journal:  Front Cell Dev Biol       Date:  2021-04-15

9.  Acute effects of coffee consumption on self-reported gastrointestinal symptoms, blood pressure and stress indices in healthy individuals.

Authors:  Emilia Papakonstantinou; Ioanna Kechribari; Κyriaki Sotirakoglou; Petros Tarantilis; Theodora Gourdomichali; George Michas; Vassiliki Kravvariti; Konstantinos Voumvourakis; Antonis Zampelas
Journal:  Nutr J       Date:  2016-03-15       Impact factor: 3.271

10.  European Guidelines for Obesity Management in Adults.

Authors:  Volkan Yumuk; Constantine Tsigos; Martin Fried; Karin Schindler; Luca Busetto; Dragan Micic; Hermann Toplak
Journal:  Obes Facts       Date:  2015-12-05       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.